Medicare GLP-1 Bridge and Sleep Apnea: Why You're Sent to Part D, and What to Do

If you have Medicare and moderate-to-severe obstructive sleep apnea, you may have heard you're "excluded" from the new $50 GLP-1 Bridge. That's true, but it isn't the dead end it sounds like. People with sleep apnea are left out of the Bridge because their Part D drug plan can already cover a GLP-1 for that condition. This guide explains how the Bridge works, who qualifies, and what to do if it doesn't apply to you.

Rules last checked November 2026. Medicare programs change, so confirm the details with your prescriber, your Part D plan, or 1-800-MEDICARE before you rely on them.

What the Medicare GLP-1 Bridge Is

The Medicare GLP-1 Bridge is a temporary CMS program that covers GLP-1 medications for weight management, which Part D plans normally can't cover. The key facts:

Dates: July 1, 2026 through December 31, 2027. It was first planned to end in 2026, and CMS extended it when it delayed the Part D part of its BALANCE model.
Cost: a $50 copay for each 30-day supply. Everyone pays the same $50, including people with Extra Help. The copay doesn't count toward your Part D deductible or yearly out-of-pocket limit.
Covered drugs: Wegovy (injection and tablet), the Zepbound KwikPen, and Foundayo. Zepbound vials and single-dose pens are not covered through the Bridge, and Ozempic isn't part of it.
No separate sign-up: if you qualify, your prescriber sends the prescription to a pharmacy as usual and the pharmacy bills the Bridge.

Who Qualifies

You need to be 18 or older and enrolled in a standalone Part D plan or a Medicare Advantage plan with drug coverage. Some plan types aren't eligible, including private fee-for-service plans, cost plans and PACE, unless you also have a standalone Part D plan.

You also need to meet one of these clinical criteria when you start the medication:

BMI	Plus
35 or higher	Nothing else required
30 or higher	Heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or above
27 or higher	Prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease (blocked arteries in the legs or arms)

Your prescriber documents this on a prior authorization request after the pharmacy submits the claim.

Who Is Sent to Part D Instead

You can't use the Bridge if:

You have moderate-to-severe obstructive sleep apnea.
You have type 2 diabetes.
You have fatty liver disease (MASH).
You already got a GLP-1 through your Part D plan in 2026.

The first three aren't penalties. Part D plans can already cover GLP-1 medications for these conditions because the FDA has approved them for those uses. Zepbound was approved for moderate-to-severe obstructive sleep apnea in adults with obesity in December 2024. Ozempic and Mounjaro are approved for type 2 diabetes, and Wegovy has approvals beyond weight loss. CMS built the Bridge for people who had no Medicare route at all, so anyone with an existing Part D route stays with their plan.

If you've already filled a GLP-1 through Part D this year, the pharmacy claim to the Bridge will be rejected and you'll be directed back to your plan.

Getting Zepbound for Sleep Apnea Through Part D

For people with sleep apnea, the Part D route can still work. What it costs depends on your plan.

Check your plan's formulary. Look up whether Zepbound is listed and what tier it's on. You can do this on your plan's website or through the Medicare Plan Finder.
Expect prior authorization. Plans that cover Zepbound for sleep apnea usually require proof of the diagnosis, typically a sleep study showing moderate-to-severe obstructive sleep apnea, plus your BMI and what you've already tried, such as CPAP. Ask your prescriber's office to include the sleep study report with the request.
Ask for a formulary exception if it isn't covered. If Zepbound isn't on your formulary, your prescriber can request an exception and explain why you need it. If that's denied, Part D has a standard appeals process.
Plan for the cost. Your share depends on your plan's tier, deductible and coinsurance. In 2026, Part D caps yearly out-of-pocket drug costs at $2,100. Some people can spread costs across the year with the Medicare Prescription Payment Plan.

Don't try to get around the sleep apnea rule by leaving the diagnosis off your records or asking your prescriber to omit it. Medical records need to be accurate, and a federal program application is not the place to bend the rules. The Part D route exists for exactly your situation.

If You Don't Qualify for Either

If the Bridge doesn't apply and your Part D plan won't cover a GLP-1 for you:

Manufacturer self-pay programs. LillyDirect (Zepbound) and NovoCare (Wegovy) sell at self-pay prices without insurance. Check their sites for current prices, since they change often.
Talk to your prescriber about your options, including whether another covered medication or treatment fits your situation.
Avoid unlicensed sellers. The FDA ended the semaglutide and tirzepatide shortages in 2024–2025, and mass-produced compounded copies are no longer permitted. Online sellers offering cheap "generic" versions are a safety risk.

What Happens After 2027

The Bridge is scheduled to end on December 31, 2027. CMS delayed the Part D part of its BALANCE model, which would have let Part D plans cover GLP-1s for weight management, and hasn't announced what replaces the Bridge after 2027. If you start through the Bridge, it's worth planning now with your prescriber for what happens if coverage ends. That includes the habits that help you hold your weight if you ever have to stop.

GLP-1 Simple can help with that last part. The free account shows the published regain curve in your own numbers, and the Off-Ramp Plan gives you a dated plan and early warnings if your weight starts to drift.

Frequently Asked Questions

Why are people with sleep apnea excluded from the Medicare GLP-1 Bridge?

Because Part D plans can already cover Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, an FDA-approved use since December 2024. The Bridge is for people who have no other Medicare route to a GLP-1. If you have sleep apnea, ask your prescriber to request coverage through your Part D plan.

How much does the Medicare GLP-1 Bridge cost?

$50 for each 30-day supply, for everyone who qualifies, including people with Extra Help. The copay doesn't count toward your Part D deductible or out-of-pocket limit.

Which drugs does the Medicare GLP-1 Bridge cover?

Wegovy (injection and tablet), the Zepbound KwikPen, and Foundayo. Zepbound vials and single-dose pens aren't covered through the Bridge, and Ozempic isn't part of it.

Can I use the Bridge if I already got a GLP-1 through Part D this year?

No. If you've filled a GLP-1 through your Part D plan in 2026, you stay with your plan. Your prescriber can ask your plan for a formulary exception if coverage is a problem.

How long does the Medicare GLP-1 Bridge last?

It runs from July 1, 2026 through December 31, 2027. CMS hasn't announced what follows it, so plan ahead with your prescriber.